These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 1884465)

  • 1. Clinical trials of restenosis after coronary angioplasty.
    Popma JJ; Califf RM; Topol EJ
    Circulation; 1991 Sep; 84(3):1426-36. PubMed ID: 1884465
    [No Abstract]   [Full Text] [Related]  

  • 2. Novel approaches for the prevention of restenosis.
    Gruberg L; Waksman R; Satler LF; Pichard AD; Kent KM
    Expert Opin Investig Drugs; 2000 Nov; 9(11):2555-78. PubMed ID: 11060820
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of cilostazol on restenosis after percutaneous coronary balloon angioplasty.
    Tsuchikane E; Fukuhara A; Kobayashi T; Kirino M; Yamasaki K; Kobayashi T; Izumi M; Otsuji S; Tateyama H; Sakurai M; Awata N
    Circulation; 1999 Jul; 100(1):21-6. PubMed ID: 10393676
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pathophysiology and pharmacological approaches for prevention of coronary artery restenosis following coronary artery balloon angioplasty and related procedures.
    Landzberg BR; Frishman WH; Lerrick K
    Prog Cardiovasc Dis; 1997; 39(4):361-98. PubMed ID: 9050821
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevention of restenosis after coronary angioplasty: towards a molecular approach?
    Feldman LJ; Riessen R; Steg PG
    Fundam Clin Pharmacol; 1995; 9(1):8-16. PubMed ID: 7768490
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diminishing impact of in-lab complications.
    Tommaso CL; Bergelson BA
    Cathet Cardiovasc Diagn; 1997 Nov; 42(3):257-8. PubMed ID: 9367095
    [No Abstract]   [Full Text] [Related]  

  • 7. Platelet activation and coronary interventions.
    Kutryk MJ; Serruys PW
    Eur Heart J; 1996 Aug; 17(8):1134-6. PubMed ID: 8869848
    [No Abstract]   [Full Text] [Related]  

  • 8. Restenosis after successful percutaneous transluminal coronary angioplasty.
    Klein LW; Rosenblum J
    Prog Cardiovasc Dis; 1990; 32(5):365-82. PubMed ID: 2179996
    [No Abstract]   [Full Text] [Related]  

  • 9. [Restenosis after percutaneous transluminal angioplasty: II. Possibilities for pharmacologic intervention].
    Böger RH; Bode-Böger SM; Alfke H
    Vasa; 1996; 25(1):21-31. PubMed ID: 8851262
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Restenosis after coronary angioplasty.
    Hamon M; Bauters C; McFadden EP; Wernert N; Lablanche JM; Dupuis B; Bertrand ME
    Eur Heart J; 1995 Aug; 16 Suppl I():33-48. PubMed ID: 8829956
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Progress in interventional cardiology.
    Talley JD
    J Interv Cardiol; 1993 Mar; 6(1):89-94. PubMed ID: 10150990
    [No Abstract]   [Full Text] [Related]  

  • 12. Antithrombotic therapy in patients undergoing coronary angioplasty.
    Popma JJ; Coller BS; Ohman EM; Bittl JA; Weitz J; Kuntz RE; Leon MB
    Chest; 1995 Oct; 108(4 Suppl):486S-501S. PubMed ID: 7555198
    [No Abstract]   [Full Text] [Related]  

  • 13. Antithrombotic therapy in patients undergoing percutaneous coronary intervention.
    Popma JJ; Ohman EM; Weitz J; Lincoff AM; Harrington RA; Berger P
    Chest; 2001 Jan; 119(1 Suppl):321S-336S. PubMed ID: 11157657
    [No Abstract]   [Full Text] [Related]  

  • 14. Pharmacological approaches to the prevention of restenosis following angioplasty. The search for the Holy Grail? (Part I).
    Herrman JP; Hermans WR; Vos J; Serruys PW
    Drugs; 1993 Jul; 46(1):18-52. PubMed ID: 7691506
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevention of restenosis after angioplasty.
    Cahill MR; Macey MG; Dawson JR; Newland AC
    Lancet; 1994 May; 343(8909):1361. PubMed ID: 7910347
    [No Abstract]   [Full Text] [Related]  

  • 16. The role of platelets, thrombin and hyperplasia in restenosis after coronary angioplasty.
    Ip JH; Fuster V; Israel D; Badimon L; Badimon J; Chesebro JH
    J Am Coll Cardiol; 1991 May; 17(6 Suppl B):77B-88B. PubMed ID: 2016486
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevention of restenosis after percutaneous transluminal coronary angioplasty: the search for a "magic bullet".
    Hermans WR; Rensing BJ; Strauss BH; Serruys PW
    Am Heart J; 1991 Jul; 122(1 Pt 1):171-87. PubMed ID: 2063736
    [No Abstract]   [Full Text] [Related]  

  • 18. [Platelet membrane glycoproteins as site of pharmacological intervention in the treatment of coronary disease].
    Neumann FJ; Gawaz M; Schömig A
    Dtsch Med Wochenschr; 1997 Oct; 122(40):1224-30. PubMed ID: 9378047
    [No Abstract]   [Full Text] [Related]  

  • 19. A mainstay drug underperforms. But a bedside test makes it easier to spot "aspirin resistance".
    Heart Advis; 2004 Aug; 7(8):3. PubMed ID: 15551431
    [No Abstract]   [Full Text] [Related]  

  • 20. Preventing coronary restenosis and complications.
    Holmes DR
    N Engl J Med; 1997 Jun; 336(24):1748-9. PubMed ID: 9180094
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.